Interestingly, sodium valproate (an epigenetic drug that inhibits HDACs) decreases TNF-α and NOS2 expression levels [41], hinting at an opportunity for autism epigenetic therapy using HDAC inhibitors. This evidence concerns the gene TNF and autism.